Advisory Services Network LLC grew its stake in Hill-Rom Holdings, Inc. (NYSE:HRC) by 31.3% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 1,050 shares of the medical technology company’s stock after purchasing an additional 250 shares during the period. Advisory Services Network LLC’s holdings in Hill-Rom were worth $111,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other institutional investors have also modified their holdings of HRC. Oregon Public Employees Retirement Fund lifted its stake in Hill-Rom by 8,755.0% during the fourth quarter. Oregon Public Employees Retirement Fund now owns 2,308,056 shares of the medical technology company’s stock worth $26,000 after purchasing an additional 2,281,991 shares in the last quarter. Hanseatic Management Services Inc. acquired a new position in Hill-Rom during the first quarter worth $30,000. Sageworth Trust Co acquired a new position in Hill-Rom during the first quarter worth $32,000. Financial Gravity Wealth Inc. acquired a new position in Hill-Rom during the first quarter worth $53,000. Finally, Osborn Williams & Donohoe LLC acquired a new position in Hill-Rom during the first quarter worth $53,000. Institutional investors own 81.34% of the company’s stock.
Shares of HRC stock traded down $0.57 during mid-day trading on Thursday, hitting $106.08. 317,574 shares of the stock were exchanged, compared to its average volume of 472,166. Hill-Rom Holdings, Inc. has a 12-month low of $81.82 and a 12-month high of $108.68. The firm’s fifty day moving average price is $103.67. The company has a market capitalization of $7.11 billion, a PE ratio of 22.33, a price-to-earnings-growth ratio of 1.84 and a beta of 0.92. The company has a quick ratio of 1.27, a current ratio of 1.69 and a debt-to-equity ratio of 1.10.
The firm also recently declared a quarterly dividend, which will be paid on Monday, September 30th. Investors of record on Friday, September 20th will be given a dividend of $0.21 per share. The ex-dividend date of this dividend is Thursday, September 19th. This represents a $0.84 dividend on an annualized basis and a yield of 0.79%. Hill-Rom’s dividend payout ratio (DPR) is 17.68%.
A number of research analysts have commented on the company. ValuEngine upgraded China Southern Airlines from a “sell” rating to a “hold” rating in a research note on Tuesday, June 11th. Barclays increased their price objective on Zimmer Biomet from $113.00 to $117.00 and gave the company an “underweight” rating in a research note on Monday, April 15th. Finally, Zacks Investment Research upgraded HENKEL AG & CO/S from a “sell” rating to a “hold” rating in a research note on Thursday, June 6th. Two equities research analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. Hill-Rom currently has an average rating of “Buy” and an average target price of $107.00.
Hill-Rom Holdings, Inc operates as a medical technology company worldwide. It operates in three segments: Patient Support Systems, Front Line Care, and Surgical Solutions. The company offers medical surgical beds, intensive care unit beds, and bariatric patient beds, lifts and other patient mobility devices, non-invasive therapeutic products and surfaces, and information technologies and software solutions; and medical equipment management services, as well as sells equipment service contracts for its capital equipment.
See Also: Understanding the two types of arbitrage
Receive News & Ratings for Hill-Rom Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom and related companies with MarketBeat.com's FREE daily email newsletter.